IDEX Corp
IEX: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$335.00 | Yyjt | Xtxfqvydh |
Idex Earnings: Strong Results Given Headwinds in Health and Science Technologies
Narrow-moat-rated Idex ended 2023 with a solid fourth quarter, as its full-year revenue of $3.3 billion and adjusted EPS of $8.22 both came in above our estimates of $3.2 billion and $8.16. After rolling our model forward one year, we’ve raised our fair value estimate to $219 from $215, which reflects our updated near-term outlook as well as time value of money.